Hikal (BOM:524735) YoY EBITDA Growth : 7.03% (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Hikal YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Hikal's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 7.03%.

Hikal's EBITDA per Share for the three months ended in Mar. 2024 was ₹7.67.

Hikal YoY EBITDA Growth Historical Data

The historical data trend for Hikal's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hikal YoY EBITDA Growth Chart

Hikal Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

YoY EBITDA Growth

Get a 7-Day Free Trial

-11.85

26.81

5.19

-22.87

2.54

Hikal Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
YoY EBITDA Growth	Get a 7-Day Free Trial															57.22	96.12	-17.34	-15.78	7.03

Hikal YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Hikal's YoY EBITDA Growth for the fiscal year that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (A: Mar. 2024 )
=	(EBITDA per Share (A: Mar. 2024 )	-	EBITDA per Share (A: Mar. 2023 ))	/	\| EBITDA per Share (A: Mar. 2023 ) \|
=	(21.837	-	21.296)	/	\| 21.296 \|
=	2.54 %

Hikal's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2024 )
=	(EBITDA per Share (Q: Mar. 2024 )	-	EBITDA per Share (Q: Mar. 2023 ))	/	\| EBITDA per Share (Q: Mar. 2023 )) \|
=	(7.67	-	7.166)	/	\| 7.166 \|
=	7.03 %

Hikal YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Hikal's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Hikal (BOM:524735) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hikal Ltd (BOM:524735) » Definitions » YoY EBITDA Growth

Traded in Other Exchanges

HIKAL:India

Address

Great Eastern Chambers, 6th Floor, Sector 11, CBD Belapur, Navi Mumbai, MH, IND, 400 614

Website

https://www.hikal.com

Hikal Ltd manufactures chemical intermediates, specialty chemicals, active pharma ingredients, and contract research activities. Its products are distributed to pharmaceuticals, biotech, agrochemicals, and specialty chemical industries. Its segments include crop protection and pharmaceuticals. The majority of the revenue is derived from the pharmaceutical segment.

Hikal (BOM:524735) Headlines

No Headlines